Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LifeMD, Inc. Director's Dealing 2018

Dec 21, 2018

33298_dirs_2018-12-21_8f4b5e28-6aea-48df-97c1-490215cf2847.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONVERSION LABS, INC. (CVLB)
CIK: 0000948320
Period of Report: 2018-12-19

Reporting Person: Schreiber Justin (Director, Chief Executive Officer, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-12-19 Common Stock, par value $0.01 P 5000 $0.1649 Acquired 3098299 Indirect
2018-12-19 Common Stock, par value $0.01 P 16701 $0.165 Acquired 3115000 Indirect
2018-12-20 Common Stock, par value $0.01 P 20000 $0.19 Acquired 3135000 Indirect
2018-12-21 Common Stock, par value $0.01 P 10000 $0.185 Acquired 3145000 Indirect

Footnotes

F1: These shares were purchased on the open market.